SYGEN Acute Spinal Cord Injury Study

Geisler, Fred H.; Dorsey, Frank C.; Patarnello, F.; Grieco, Giulia; Poonian, Devinder; Fiorentini, R.

doi:10.1097/00006123-199809000-00322

Search citation statements

Order By: Relevance

Paper Sections

Select...

Gm-1 Gangliozid1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Omurilik yaralanmalı hastalarda iyileşme için başlangıç sonuçları, plasebo alan kişiler ile kıyaslandığında, ilacı alan kişilerde umut verici olmuş fakat daha geniş çok merkezli çalışmalarda uzun süreli takipler ile bu sonuçlar elde edilememiştir (10) .…”

Section: Gm-1 Gangliozidunclassified

Medical Treatment in Spinal Cord Injury

Can

Savrunlu

Kabataş

2021

SSCD

View full text Add to dashboard Cite

Spinal cord injuries cause psychological in humans and require expensive care and treatments. In recent years, various pharmacological agents have been tested in acute spinal cord injuries. Prospective randomized controlled clinical trials on a large scale have failed to demonstrate significant neurological progression, in contrast to their success in the laboratory. The search for an effective neuroprotective pharmacological agent to prevent secondary damage in acute spinal cord injuries remains primary goals for basic sciences and clinicians.

show abstract

Section: Gm-1 Gangliozidunclassified